FM
AEGR

Forward Management’s Aegerion Pharmaceuticals AEGR Stock Holding History

Forward Management’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-4,600
Closed -$87K – 325
2015
Q2 		$87K Hold
4,600
– – 0.01% 297
2015
Q1 		$120K Hold
4,600
– – 0.01% 322
2014
Q4 		$96K Sell
4,600
-7,500
-62% -$189K 0.01% 337
2014
Q3 		$404K Sell
12,100
-48,600
-80% -$1.51M 0.02% 247
2014
Q2 		$1.9M Sell
60,700
-1,314
-2% -$48.9K 0.11% 111
2014
Q1 		$2.69M Buy
62,014
+26,154
+73% +$1.53M 0.15% 84
2013
Q4 		$2.21M Buy
35,860
+7,050
+24% +$539K 0.13% 91
2013
Q3 		$1.84M Buy
28,810
+5,270
+22% +$447K 0.12% 106
2013
Q2 		$1.09M Buy
+23,540
New +$1.25M 0.09% 144

Other funds holding AEGR

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Forward Management's AEGR Position: Q3 2015 in Review

Forward Management sold out of Aegerion Pharmaceuticals (AEGR) in Q3 2015, closing a stake of 4,600 shares — an estimated $87K sold.

Forward Management first reported a position in AEGR in Q2 2013 and held it in 9 quarters. The position peaked at $2.69M in Q1 2014. 96 funds tracked by Wall St. Rank hold AEGR as of Q3 2015.

  • Forward Management reported no remaining Aegerion Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Forward Management sold 4,600 Aegerion Pharmaceuticals shares in Q3 2015, an estimated $87K.
  • Forward Management first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 9 quarters.
  • Forward Management's Aegerion Pharmaceuticals position peaked at $2.69M in Q1 2014.
  • 96 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q3 2015.

Based on Forward Management's 13F filing for Q3 2015, filed 9 Nov 2015.